What we're reading, January 6, 2017: some Democrats are appealing to the GOP to consider bipartisan efforts to overhaul Obamacare instead of repealing it; enrollment for Affordable Care Act plans is up 2.3% over last year; and Democrats demand an ethics probe into Tom Price's stock trades.
Some Democrats, led by Hillary Clinton’s running mate, Senator Tim Kaine, D-Virginia, are appealing to the GOP to consider a bipartisan effort to overhaul the Affordable Care Act (ACA) instead of completely repealing it. According to The New York Times, the opportunity for cooperation could be short lived. If Republicans go forward with the repeal, those same Democrats willing to work on an overhaul will be uncooperative when it comes to creating a replacement plan further down the road.
Meanwhile, enrollment in the ACA keeps rolling along. Sign-ups for coverage in ACA plans are up 2.3% over the same time last year, with 8.8 million people signed up through HealthCare.gov as of December 31, according to Bloomberg. This number only includes sign-ups through the exchange site run by the federal government. Sign-ups in California, New York, and other states that run their own systems were not included in the tally.
As the parties fight it out over the ACA, Democrats are also paying attention to President-elect Donald J. Trump’s nominees for various positions in his administration. Reuters reported that Democrats are demanding an ethics probe into Trump’s pick for HHS, Georgia Congressman Tom Price. The Democrats are calling on the Office of Congressional Ethics to investigate Price’s stock trades—over the last 4 years, he bought and sold more than $300,000 in stocks in biomedical and pharmaceutical companies. During that time, he also sponsored legislation that could have influenced those companies’ shares.
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
California Aims for Equity by Redefining Cancer Care
December 8th 2023Authors highlight key aspects of the California Cancer Care Equity Act, including its focus on Medi-Cal beneficiaries, the requirement for managed care plans to contract with specialized cancer centers, and the definition of complex cancers.
Read More
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
Patients With RA in Remission Withdrawing From TNF Inhibition Show Flare Increases
December 8th 2023New data presented at ACR 2023 highlighted the differences in rates of flares and Boolean 2.0 remission rates compared to patients with rheumatoid arthritis who continued a tumor necrosis factor inhibitor (TNFi).
Read More
New Insights on Breast Cancer Outcomes Among Sexual, Gender Minorities
December 7th 2023Despite there being a great demand for data collection on sexual orientation and gender identity in the cancer space, individuals who identify as a sexual and gender minority remain poorly represented.
Read More